Shibeshi W, Baye A, Alemkere G, Engidawork E
Ther Clin Risk Manag. 2022; 17:1353-1370.
PMID: 35221688
PMC: 8866990.
DOI: 10.2147/TCRM.S336771.
Gonzalez R, Nhampossa T, Mombo-Ngoma G, Mischlinger J, Esen M, Tchouatieu A
BMJ Open. 2021; 11(11):e053197.
PMID: 34815285
PMC: 8611429.
DOI: 10.1136/bmjopen-2021-053197.
Saito M, Mansoor R, Kennon K, Anvikar A, Ashley E, Chandramohan D
Lancet Infect Dis. 2020; 20(8):943-952.
PMID: 32530424
PMC: 7391007.
DOI: 10.1016/S1473-3099(20)30064-5.
Clark E, Serpa J
Curr Infect Dis Rep. 2019; 21(12):49.
PMID: 31734888
DOI: 10.1007/s11908-019-0703-8.
Saito M, Mansoor R, Wiladphaingern J, Paw M, Pimanpanarak M, Proux S
Open Forum Infect Dis. 2019; 6(7):ofz264.
PMID: 31281861
PMC: 6602886.
DOI: 10.1093/ofid/ofz264.
Risk of sudden unexplained death after use of dihydroartemisinin-piperaquine for malaria: a systematic review and Bayesian meta-analysis.
Chan X, Win Y, Mawer L, Tan J, Brugada J, White N
Lancet Infect Dis. 2018; 18(8):913-923.
PMID: 29887371
PMC: 6060085.
DOI: 10.1016/S1473-3099(18)30297-4.
Treatment of uncomplicated and severe malaria during pregnancy.
DAlessandro U, Hill J, Tarning J, Pell C, Webster J, Gutman J
Lancet Infect Dis. 2018; 18(4):e133-e146.
PMID: 29395998
PMC: 6590069.
DOI: 10.1016/S1473-3099(18)30065-3.
Methodology of assessment and reporting of safety in anti-malarial treatment efficacy studies of uncomplicated falciparum malaria in pregnancy: a systematic literature review.
Saito M, Gilder M, Nosten F, Guerin P, McGready R
Malar J. 2017; 16(1):491.
PMID: 29254487
PMC: 5735519.
DOI: 10.1186/s12936-017-2136-x.
Systematic literature review and meta-analysis of the efficacy of artemisinin-based and quinine-based treatments for uncomplicated falciparum malaria in pregnancy: methodological challenges.
Saito M, Gilder M, Nosten F, McGready R, Guerin P
Malar J. 2017; 16(1):488.
PMID: 29237461
PMC: 5729448.
DOI: 10.1186/s12936-017-2135-y.
Intermittent Preventive Treatment With Dihydroartemisinin-Piperaquine for the Prevention of Malaria Among HIV-Infected Pregnant Women.
Natureeba P, Kakuru A, Muhindo M, Ochieng T, Ategeka J, Koss C
J Infect Dis. 2017; 216(1):29-35.
PMID: 28329368
PMC: 5853208.
DOI: 10.1093/infdis/jix110.
Safety, tolerability, and efficacy of repeated doses of dihydroartemisinin-piperaquine for prevention and treatment of malaria: a systematic review and meta-analysis.
Gutman J, Kovacs S, Dorsey G, Stergachis A, Kuile F
Lancet Infect Dis. 2016; 17(2):184-193.
PMID: 27865890
PMC: 5266794.
DOI: 10.1016/S1473-3099(16)30378-4.
Dihydroartemisinin-Piperaquine for the Prevention of Malaria in Pregnancy.
Kakuru A, Jagannathan P, Muhindo M, Natureeba P, Awori P, Nakalembe M
N Engl J Med. 2016; 374(10):928-39.
PMID: 26962728
PMC: 4847718.
DOI: 10.1056/NEJMoa1509150.
Safety, tolerability and pharmacokinetic properties of coadministered azithromycin and piperaquine in pregnant Papua New Guinean women.
Moore B, Benjamin J, Auyeung S, Salman S, Yadi G, Griffin S
Br J Clin Pharmacol. 2016; 82(1):199-212.
PMID: 26889763
PMC: 4917786.
DOI: 10.1111/bcp.12910.
Intervals to Plasmodium falciparum recurrence after anti-malarial treatment in pregnancy: a longitudinal prospective cohort.
Laochan N, Zaloumis S, Imwong M, Lek-Uthai U, Brockman A, Sriprawat K
Malar J. 2015; 14:221.
PMID: 26017553
PMC: 4449611.
DOI: 10.1186/s12936-015-0745-9.
Stability profiling of anti-malarial drug piperaquine phosphate and impurities by HPLC-UV, TOF-MS, ESI-MS and NMR.
Yan F, Liu J, Zeng X, Zhang Y, Hang T
Malar J. 2014; 13:401.
PMID: 25311421
PMC: 4210591.
DOI: 10.1186/1475-2875-13-401.
Safety, pharmacokinetics and efficacy of artemisinins in pregnancy.
Ades V
Infect Dis Rep. 2014; 3(1):e8.
PMID: 24470906
PMC: 3892602.
DOI: 10.4081/idr.2011.e8.
Dihydroartemisinin-piperaquine treatment of multidrug resistant falciparum and vivax malaria in pregnancy.
Poespoprodjo J, Fobia W, Kenangalem E, Lampah D, Sugiarto P, Tjitra E
PLoS One. 2014; 9(1):e84976.
PMID: 24465458
PMC: 3894943.
DOI: 10.1371/journal.pone.0084976.
Efficacy of quinine, artemether-lumefantrine and dihydroartemisinin-piperaquine as rescue treatment for uncomplicated malaria in Ugandan children.
Yeka A, Tibenderana J, Achan J, DAlessandro U, Talisuna A
PLoS One. 2013; 8(1):e53772.
PMID: 23349741
PMC: 3551967.
DOI: 10.1371/journal.pone.0053772.
Pharmacokinetics of piperaquine in pregnant women in Sudan with uncomplicated Plasmodium falciparum malaria.
Adam I, Tarning J, Lindegardh N, Mahgoub H, McGready R, Nosten F
Am J Trop Med Hyg. 2012; 87(1):35-40.
PMID: 22764289
PMC: 3391055.
DOI: 10.4269/ajtmh.2012.11-0410.
Dihydroartemisinin/Piperaquine: a review of its use in the treatment of uncomplicated Plasmodium falciparum malaria.
Keating G
Drugs. 2012; 72(7):937-61.
PMID: 22515619
DOI: 10.2165/11203910-000000000-00000.